Free Trial

PureTech Health (PRTC) Competitors

PureTech Health logo
$18.03 +0.40 (+2.25%)
As of 03:26 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PRTC vs. TLRY, IMCR, ABCL, VCEL, BHVN, GPCR, EWTX, HROW, HRMY, and SDGR

Should you be buying PureTech Health stock or one of its competitors? The main competitors of PureTech Health include Tilray Brands (TLRY), Immunocore (IMCR), AbCellera Biologics (ABCL), Vericel (VCEL), Biohaven (BHVN), Structure Therapeutics (GPCR), Edgewise Therapeutics (EWTX), Harrow (HROW), Harmony Biosciences (HRMY), and Schrodinger (SDGR). These companies are all part of the "pharmaceutical products" industry.

PureTech Health vs. Its Competitors

Tilray Brands (NASDAQ:TLRY) and PureTech Health (NASDAQ:PRTC) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations and valuation.

In the previous week, Tilray Brands had 31 more articles in the media than PureTech Health. MarketBeat recorded 35 mentions for Tilray Brands and 4 mentions for PureTech Health. Tilray Brands' average media sentiment score of 0.71 beat PureTech Health's score of 0.62 indicating that Tilray Brands is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
14 Very Positive mention(s)
5 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PureTech Health
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

PureTech Health has lower revenue, but higher earnings than Tilray Brands.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray Brands$821.31M2.26-$2.19B-$2.27-0.74
PureTech Health$6.17M70.65$27.78MN/AN/A

Tilray Brands has a beta of 1.98, indicating that its stock price is 98% more volatile than the S&P 500. Comparatively, PureTech Health has a beta of 1.13, indicating that its stock price is 13% more volatile than the S&P 500.

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 0.0% of PureTech Health shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by company insiders. Comparatively, 5.3% of PureTech Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

PureTech Health has a net margin of 0.00% compared to Tilray Brands' net margin of -258.54%. PureTech Health's return on equity of 0.00% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-258.54% -6.79% -5.30%
PureTech Health N/A N/A N/A

Tilray Brands presently has a consensus target price of $2.00, indicating a potential upside of 18.69%. Given Tilray Brands' stronger consensus rating and higher probable upside, equities analysts plainly believe Tilray Brands is more favorable than PureTech Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
2 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00
PureTech Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Tilray Brands beats PureTech Health on 8 of the 14 factors compared between the two stocks.

Get PureTech Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRTC vs. The Competition

MetricPureTech HealthMED IndustryMedical SectorNASDAQ Exchange
Market Cap$436.35M$3.40B$6.05B$10.51B
Dividend YieldN/A2.30%5.73%4.80%
P/E RatioN/A23.0384.9327.30
Price / Sales70.65268.08515.79197.96
Price / Cash7.3946.9537.5761.53
Price / Book1.0610.5412.426.82
Net Income$27.78M-$52.58M$3.32B$276.59M
7 Day Performance-3.94%0.59%0.53%0.00%
1 Month Performance17.13%15.50%10.24%7.96%
1 Year Performance-11.55%18.01%75.92%35.10%

PureTech Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRTC
PureTech Health
0.1829 of 5 stars
$18.03
+2.2%
N/A-11.9%$436.35M$6.17M0.00100Gap Down
TLRY
Tilray Brands
2.3473 of 5 stars
$1.61
+1.7%
$1.94
+20.6%
+0.6%$1.78B$210.48M-0.702,842Earnings Report
Options Volume
IMCR
Immunocore
2.2847 of 5 stars
$34.43
+1.2%
$56.89
+65.3%
-1.5%$1.73B$310.20M-86.06320
ABCL
AbCellera Biologics
2.2514 of 5 stars
$5.76
-2.0%
$8.00
+39.0%
+123.0%$1.73B$32.88M-10.50500
VCEL
Vericel
3.3561 of 5 stars
$33.90
+0.5%
$60.40
+78.2%
-17.7%$1.70B$237.22M281.11300Analyst Forecast
Analyst Revision
BHVN
Biohaven
2.9711 of 5 stars
$15.70
-1.2%
$48.85
+211.2%
-68.6%$1.65BN/A-2.03239
GPCR
Structure Therapeutics
3.2003 of 5 stars
$28.57
-0.4%
$68.67
+140.3%
-17.7%$1.64BN/A-27.17136Positive News
EWTX
Edgewise Therapeutics
2.8055 of 5 stars
$15.32
-0.2%
$38.83
+153.5%
-53.8%$1.62BN/A-9.9060
HROW
Harrow
2.7602 of 5 stars
$41.90
-0.6%
$68.50
+63.5%
-22.7%$1.56B$227.66M-168.42180
HRMY
Harmony Biosciences
4.7039 of 5 stars
$27.12
+2.0%
$45.50
+67.8%
-24.4%$1.56B$772.53M8.73200Analyst Forecast
SDGR
Schrodinger
2.6422 of 5 stars
$20.67
-2.9%
$26.57
+28.6%
+9.0%$1.52B$237.92M-8.33790Analyst Forecast

Related Companies and Tools


This page (NASDAQ:PRTC) was last updated on 10/15/2025 by MarketBeat.com Staff
From Our Partners